220 related articles for article (PubMed ID: 32134428)
1. Incidence and Mortality Risk Spectrum Across Aggressive Variants of Papillary Thyroid Carcinoma.
Ho AS; Luu M; Barrios L; Chen I; Melany M; Ali N; Patio C; Chen Y; Bose S; Fan X; Mallen-St Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
JAMA Oncol; 2020 May; 6(5):706-713. PubMed ID: 32134428
[TBL] [Abstract][Full Text] [Related]
2. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
3. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
4. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
Feng J; Shen F; Cai W; Gan X; Deng X; Xu B
Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
[TBL] [Abstract][Full Text] [Related]
6. Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.
Pizzimenti C; Fiorentino V; Ieni A; Martini M; Tuccari G; Lentini M; Fadda G
Endocrine; 2022 Oct; 78(1):1-12. PubMed ID: 35864338
[TBL] [Abstract][Full Text] [Related]
7. Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.
Russo M; Malandrino P; Moleti M; Vermiglio F; Violi MA; Marturano I; Minaldi E; Vigneri R; Pellegriti G; Regalbuto C
J Endocrinol Invest; 2017 Nov; 40(11):1235-1241. PubMed ID: 28528434
[TBL] [Abstract][Full Text] [Related]
8. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Histologic Grade for Papillary Thyroid Carcinoma.
Ho AS; Luu M; Barrios L; Balzer BL; Bose S; Fan X; Walgama E; Mallen-St Clair J; Alam U; Shafqat I; Lin DC; Chen Y; Van Eyk JE; Maghami EG; Braunstein GD; Sacks WL; Zumsteg ZS
Ann Surg Oncol; 2021 Mar; 28(3):1731-1739. PubMed ID: 32808161
[TBL] [Abstract][Full Text] [Related]
10. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of papillary thyroid carcinoma with tall-cell features.
Ganly I; Ibrahimpasic T; Rivera M; Nixon I; Palmer F; Patel SG; Tuttle RM; Shah JP; Ghossein R
Thyroid; 2014 Apr; 24(4):662-70. PubMed ID: 24262069
[TBL] [Abstract][Full Text] [Related]
12. Follicular and Diffuse Sclerosing Variant Papillary Thyroid Carcinomas as Independent Predictive Factors of Loco-Regional Recurrence: A Comparison Study Using Propensity Score Matching.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 Aug; 26(8):1077-84. PubMed ID: 27324748
[TBL] [Abstract][Full Text] [Related]
13. Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma Is Related to a Poor Outcome: A Comparison Study Using Propensity Score Matching.
Yang L; Zhao M; Xiao L; Li L; Dong P
Endocr Pract; 2023 Oct; 29(10):779-786. PubMed ID: 37169176
[TBL] [Abstract][Full Text] [Related]
14. Tall Cell Variant of Papillary Thyroid Carcinoma: Impact of Change in WHO Definition and Molecular Analysis.
Wong KS; Higgins SE; Marqusee E; Nehs MA; Angell T; Barletta JA
Endocr Pathol; 2019 Mar; 30(1):43-48. PubMed ID: 30565013
[TBL] [Abstract][Full Text] [Related]
15. LATERAL NECK DISSECTION FOR AGGRESSIVE VARIANTS OF WELL-DIFFERENTIATED THYROID CANCER.
Lombardi D; Taboni S; Paderno A; Giordano D; Bertagna F; Albano D; Barbieri V; Spriano G; Mercante G; Piana S; Bellafiore S; Cappelli C; Nicolai P
Endocr Pract; 2019 Apr; 25(4):328-334. PubMed ID: 30995431
[No Abstract] [Full Text] [Related]
16. Liquid-based cytology improves preoperative diagnostic accuracy of the tall cell variant of papillary thyroid carcinoma.
Lee SH; Jung CK; Bae JS; Jung SL; Choi YJ; Kang CS
Diagn Cytopathol; 2014 Jan; 42(1):11-7. PubMed ID: 23754825
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
[TBL] [Abstract][Full Text] [Related]
18. Do aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classic papillary thyroid carcinoma?
Song E; Jeon MJ; Oh HS; Han M; Lee YM; Kim TY; Chung KW; Kim WB; Shong YK; Song DE; Kim WG
Eur J Endocrinol; 2018 Sep; 179(3):135-142. PubMed ID: 29875289
[TBL] [Abstract][Full Text] [Related]
19. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
[TBL] [Abstract][Full Text] [Related]
20. Cytopathology of high-grade papillary thyroid carcinomas: tall-cell variant, diffuse sclerosing variant, and poorly differentiated papillary carcinoma.
Ohori NP; Schoedel KE
Diagn Cytopathol; 1999 Jan; 20(1):19-23. PubMed ID: 9884822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
